Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Apr 30, 2007	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001157523-07-004264.pdf 0001157523-07-004264.rtf
Apr 25, 2007	EFFECT	EFFECT	View HTML 9999999995-07-001467.pdf 9999999995-07-001467.rtf 9999999995-07-001467.xls
Apr 23, 2007	CORRESP	CORRESP	View HTML 0001157523-07-003889.pdf 0001157523-07-003889.rtf
Apr 19, 2007	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001157523-07-003821.pdf 0001157523-07-003821.rtf
Apr 16, 2007	RW	Withdrawal of registration statement filed under the Securities Act	View HTML 0001104659-07-028510.pdf 0001104659-07-028510.rtf 0001104659-07-028510.xls
Apr 16, 2007	SB-2/A	Pre-effective amendment to an SB-2 filing	View HTML 0001104659-07-028513.pdf 0001104659-07-028513.rtf 0001104659-07-028513.xls
Apr 11, 2007	SB-2	Optional form for the registration of securities to be sold to the public by small business issuers	View HTML 0001104659-07-027540.pdf 0001104659-07-027540.rtf 0001104659-07-027540.xls
Mar 29, 2007	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001157523-07-003093.pdf 0001157523-07-003093.rtf
Mar 16, 2007	8-K	Report of unscheduled material events or corporate event	View HTML 0001157523-07-002747.pdf 0001157523-07-002747.rtf
Feb 28, 2007	8-K	Report of unscheduled material events or corporate event	View HTML 0001157523-07-002111.pdf 0001157523-07-002111.rtf 0001157523-07-002111.xls